Provera and Halcion drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Provera (medroxyprogesterone acetate) and Halcion (triazolam). Common drug interactions include hyperlipidaemia among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Provera and Halcion. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Provera?

Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 54,943 Provera users. Check the latest studies of Provera.

What is Halcion?

Halcion has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 8,268 Halcion users. Check the latest studies of Halcion.



On Jul, 15, 2026

27 people who take Provera and Halcion together, and have interactions are studied.

Provera and Halcion drug interactions.

What are the common drug interactions of Provera and Halcion, by gender? *:

female:

  1. Hyperlipidaemia (presence of excess lipids in the blood)
  2. Loss of consciousness
  3. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  4. Pulmonary hypertension (increase in blood pressure in the lung artery)
  5. Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)
  6. Weight increased
  7. Blood pressure decreased
  8. Breast cancer
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Pain

male:

  1. Confusional state
  2. Agitation (state of anxiety or nervous excitement)
  3. Decreased appetite
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Death
  6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

What are the common drug interactions of Provera and Halcion, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Injury
  2. Ovarian cyst (fluid filled sac of the ovary)
  3. Pain
  4. Uterine cyst
  5. Uterine perforation (accidental puncture of the uterus)

30-39:

n/a

40-49:

n/a

50-59:

  1. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  2. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  3. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  4. Gastric ulcer (stomach ulcer)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Loss of consciousness
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Reflux oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus)
  9. Blood pressure decreased
  10. Renal disorder (kidney disease)

60+:

  1. Confusional state
  2. Pulmonary hypertension (increase in blood pressure in the lung artery)
  3. Breast cancer female
  4. Cardiac failure
  5. Chest pain
  6. Death
  7. Depressed level of consciousness
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  9. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  10. Drug effect decreased

What are the existing conditions these people have? *

  1. High Blood Pressure: 8 people, 29.63%
  2. Hepatic Neoplasm Malignant (liver cancer): 8 people, 29.63%
  3. Enlarged Prostate: 8 people, 29.63%
  4. Diabetes: 8 people, 29.63%
  5. Oesophagitis (inflammation of oesophagus): 7 people, 25.93%
  6. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 25.93%
  7. Abdominal Pain: 7 people, 25.93%
  8. Menopausal Symptoms: 4 people, 14.81%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 14.81%
  10. Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Provera and Halcion?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Provera and Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Provera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halcion and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate and triazolam (the active ingredients of Provera and Halcion, respectively), and Provera and Halcion (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: